1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Beckey Trinh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Osilodrostat (Isturisa), Placebo, hydrocortisone 10mg - Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2) | Phase 2 | Not yet recruiting | Beckey Trinh | 44 | 2026-11-01 | 2026-11-06 |
Cushing Syndrome (1) · Diabetes Mellitus, Type 2 (1)
Hydrocortisone (1) · Osilodrostat (1)
Switzerland (1)